C1QB and metabolic dysfunction-associated steatotic liver disease: We subsequently conducted Mendelian randomization analysis of C1QB for the three diseases, As shown in Figure 6, MR analyses revealed no causal role of C1QB in weight loss, liver cirrhosis or nonalcoholic fatty liver disease risk.